These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 19297224

  • 1. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study.
    Petersson U, Ostgren CJ, Brudin L, Brismar K, Nilsson PM.
    Diabetes Metab; 2009 Jun; 35(3):198-205. PubMed ID: 19297224
    [Abstract] [Full Text] [Related]

  • 2. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL, Elofsson S, Brismar K.
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
    [Abstract] [Full Text] [Related]

  • 3. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25).
    López-Bermejo A, Khosravi J, Fernández-Real JM, Hwa V, Pratt KL, Casamitjana R, Garcia-Gil MM, Rosenfeld RG, Ricart W.
    Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698
    [Abstract] [Full Text] [Related]

  • 4. A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.
    Petersson U, Ostgren CJ, Brudin L, Nilsson PM.
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):536-40. PubMed ID: 19357517
    [Abstract] [Full Text] [Related]

  • 5. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults.
    Kaplan RC, McGinn AP, Pollak MN, Kuller L, Strickler HD, Rohan TE, Xue X, Kritchevsky SB, Newman AB, Psaty BM.
    J Am Geriatr Soc; 2008 Apr; 56(4):652-60. PubMed ID: 18312313
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.
    Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM.
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):371-6. PubMed ID: 16915540
    [Abstract] [Full Text] [Related]

  • 7. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score.
    Tuomilehto J, Lindström J, Hellmich M, Lehmacher W, Westermeier T, Evers T, Brückner A, Peltonen M, Qiao Q, Chiasson JL.
    Diabetes Res Clin Pract; 2010 Feb; 87(2):267-74. PubMed ID: 20022651
    [Abstract] [Full Text] [Related]

  • 8. Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus.
    Akturk M, Arslan M, Altinova A, Ozdemir A, Ersoy R, Yetkin I, Ayvali E, Gonen S, Toruner F.
    Growth Horm IGF Res; 2007 Jun; 17(3):186-93. PubMed ID: 17329141
    [Abstract] [Full Text] [Related]

  • 9. IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes.
    Wallander M, Norhammar A, Malmberg K, Ohrvik J, Rydén L, Brismar K.
    Diabetes Care; 2007 Sep; 30(9):2343-8. PubMed ID: 17563335
    [Abstract] [Full Text] [Related]

  • 10. Altered response of insulin-like growth factor-binding protein 1 to nutritional deprivation in type 2 diabetes mellitus.
    Lewitt MS, Hall K, Bang P, Brismar K.
    Metabolism; 2005 Mar; 54(3):275-80. PubMed ID: 15736102
    [Abstract] [Full Text] [Related]

  • 11. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C, Gilardini L, Pontiggia B, Morabito F, Mazzilli G, Viberti G.
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [Abstract] [Full Text] [Related]

  • 12. Cataract in type 2 diabetes mellitus in Isfahan, Iran: incidence and risk factors.
    Janghorbani M, Amini M.
    Ophthalmic Epidemiol; 2004 Dec; 11(5):347-58. PubMed ID: 15590582
    [Abstract] [Full Text] [Related]

  • 13. Sleep duration as a risk factor for the development of type 2 diabetes or impaired glucose tolerance: analyses of the Quebec Family Study.
    Chaput JP, Després JP, Bouchard C, Astrup A, Tremblay A.
    Sleep Med; 2009 Sep; 10(8):919-24. PubMed ID: 19332380
    [Abstract] [Full Text] [Related]

  • 14. Incidence of diabetes and pre-diabetes in a selected urban south Indian population (CUPS-19).
    Mohan V, Deepa M, Anjana RM, Lanthorn H, Deepa R.
    J Assoc Physicians India; 2008 Mar; 56():152-7. PubMed ID: 18697630
    [Abstract] [Full Text] [Related]

  • 15. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH, Hong J, Lü AK, Chen Y, Shen WF, Li XY, Ning G.
    Chin Med J (Engl); 2008 Dec 20; 121(24):2509-16. PubMed ID: 19187587
    [Abstract] [Full Text] [Related]

  • 16. Biological variation in fasting serum insulin-like growth factor binding protein-1 (IGFBP-1) among individuals with a varying glucose tolerance.
    Borai A, Livingstone C, Mehta S, Zarif H, Abdelaal F, Ferns G.
    Clin Biochem; 2009 Aug 20; 42(12):1270-4. PubMed ID: 19463807
    [Abstract] [Full Text] [Related]

  • 17. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study.
    Guerrero-Romero F, Rascón-Pacheco RA, Rodríguez-Morán M, de la Peña JE, Wacher N.
    Eur J Clin Invest; 2008 Jun 20; 38(6):389-96. PubMed ID: 18489400
    [Abstract] [Full Text] [Related]

  • 18. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study.
    Valdés S, Botas P, Delgado E, Alvarez F, Cadórniga FD.
    Diabetes Care; 2007 Sep 20; 30(9):2258-63. PubMed ID: 17536076
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone and insulin-like growth factor binding protein-1 responses to oral glucose in patients with primary hyperparathyroidism.
    Díez JJ, Grande C, Méndez J, González-Gancedo P, Iglesias P.
    Clin Endocrinol (Oxf); 2006 Jul 20; 65(1):27-34. PubMed ID: 16817815
    [Abstract] [Full Text] [Related]

  • 20. [Association of body size at birth with impaired glucose tolerance during their adulthood for men and women aged 41 to 47 years in Beijing of China].
    Mi J, Law CM, Zhang K, Liu S, Xu H, Shen Y, Liu J, Xu Y.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Jul 20; 33(4):209-13. PubMed ID: 11864479
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.